Medpace Holdings, Inc.MEDPEarnings & Financial Report
Nasdaq · Industrials · Services-Commercial Physical & Biological Research
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| August J. Troendle | 19.40% | 6.1M | ▼ -1.40pp | 2024-03-08 |
| The Vanguard Group | 8.33% | 2.6M | — | 2024-02-13 |
| BlackRock, Inc. | 7.90% | 2.4M | — | 2024-01-26 |
| Wasatch Advisors LP | 3.90% | — | — | 2024-02-09 |
Insider Transactions
Net 90d: −$14.44M · buys $0 / sells $14.44MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Kraft Robert O. | Director | Option exercise | 33 | — | — |
| 2026-03-31 | Carley Brian T | Director | Option exercise | 36 | — | — |
| 2026-03-31 | McCarthy Cornelius P. III | Director | Option exercise | 29 | — | — |
| 2026-03-18 | BURWIG SUSAN E | Exec. VP, Operations | Option exercise | 12.0K | $166.73 | $2.00M |
| 2026-03-17 | GEIGER JESSE J | President | Option exercise | 31.7K | $138.87 | $4.40M |
| 2026-03-17 | GEIGER JESSE J | President | Sell (open market) | 31.7K | $455.30 | $14.44M |
| 2026-02-17 | EWALD STEPHEN P | General Counsel & Corp. Secy. | Option exercise | 3.5K | $138.87 | $486.0K |
| 2026-02-13 | BURWIG SUSAN E | Exec. VP, Operations | Option exercise | 11.0K | $107.93 | $1.19M |
| 2026-02-13 | Carley Brian T | Director | Option exercise | 6.5K | $54.99 | $355.9K |
1–9 of 9